NYSE:BAX - Baxter International Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$77.24 -1.21 (-1.54 %)
(As of 03/22/2019 04:00 PM ET)
Previous Close$78.45
Today's Range$77.17 - $78.52
52-Week Range$61.05 - $78.52
Volume2.77 million shs
Average Volume3.13 million shs
Market Capitalization$39.59 billion
P/E Ratio25.32
Dividend Yield0.97%
Beta1
Baxter International Inc. provides a portfolio of healthcare products. The company operates through North and South America; Europe, Middle East and Africa; and Asia-Pacific segments. It offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; renal replacement therapies and other organ support therapies focused in the intensive care unit; sterile intravenous (IV) solutions, IV therapies, infusion pumps, administration sets, and drug reconstitution devices; and parenteral nutrition therapies. The company also provides biological products and medical devices, and surgical hemostat and sealant products used in surgical procedures for hemostasis, tissue sealing, and adhesion prevention; premixed and oncology drug platforms, inhaled anesthesia and critical care products, and pharmacy compounding services; and generic injectable pharmaceuticals. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and by patients at home under physician supervision. The company sells its products through direct sales force, independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules. Baxter International Inc. was founded in 1931 and is headquartered in Deerfield, Illinois.

Receive BAX News and Ratings via Email

Sign-up to receive the latest news and ratings for BAX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment
SectorMedical
CUSIP07181310
Phone224-948-2000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$11.13 billion
Cash Flow$4.6086 per share
Book Value$14.69 per share

Profitability

Net Income$1.62 billion

Miscellaneous

Employees50,000
Market Cap$39.59 billion
Next Earnings Date4/25/2019 (Confirmed)
OptionableOptionable

Baxter International (NYSE:BAX) Frequently Asked Questions

What is Baxter International's stock symbol?

Baxter International trades on the New York Stock Exchange (NYSE) under the ticker symbol "BAX."

How often does Baxter International pay dividends? What is the dividend yield for Baxter International?

Baxter International declared a quarterly dividend on Tuesday, February 19th. Investors of record on Friday, March 1st will be given a dividend of $0.19 per share on Monday, April 1st. This represents a $0.76 annualized dividend and a dividend yield of 0.98%. The ex-dividend date of this dividend is Thursday, February 28th. View Baxter International's Dividend History.

How will Baxter International's stock buyback program work?

Baxter International announced that its board has approved a stock repurchase plan on Tuesday, November 13th 2018, which allows the company to repurchase $2,000,000,000.00 in shares, according to EventVestor. This repurchase authorization allows the company to repurchase up to 6.1% of its shares through open market purchases. Shares repurchase plans are generally a sign that the company's board of directors believes its shares are undervalued.

How were Baxter International's earnings last quarter?

Baxter International Inc (NYSE:BAX) issued its earnings results on Thursday, January, 31st. The medical instruments supplier reported $0.78 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.73 by $0.05. The medical instruments supplier had revenue of $2.84 billion for the quarter, compared to analyst estimates of $2.80 billion. Baxter International had a net margin of 14.60% and a return on equity of 19.10%. View Baxter International's Earnings History.

When is Baxter International's next earnings date?

Baxter International is scheduled to release their next quarterly earnings announcement on Thursday, April 25th 2019. View Earnings Estimates for Baxter International.

How can I listen to Baxter International's earnings call?

Baxter International will be holding an earnings conference call on Thursday, April 25th at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at 8448861929.

What guidance has Baxter International issued on next quarter's earnings?

Baxter International issued an update on its FY19 earnings guidance on Thursday, January, 31st. The company provided EPS guidance of $3.22-3.30 for the period, compared to the Thomson Reuters consensus EPS estimate of $3.27. The company issued revenue guidance of ~$11.1-11.2 billion, compared to the consensus revenue estimate of $11.37 billion.Baxter International also updated its FY 2019 guidance to $3.22-3.30 EPS.

What price target have analysts set for BAX?

15 brokerages have issued 12-month price targets for Baxter International's stock. Their forecasts range from $70.00 to $85.00. On average, they anticipate Baxter International's stock price to reach $76.7333 in the next twelve months. This suggests that the stock has a possible downside of 0.7%. View Analyst Price Targets for Baxter International.

What is the consensus analysts' recommendation for Baxter International?

15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Baxter International in the last year. There are currently 3 hold ratings and 12 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Baxter International.

Has Baxter International been receiving favorable news coverage?

News stories about BAX stock have trended somewhat positive on Saturday, InfoTrie Sentiment reports. InfoTrie identifies negative and positive press coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Baxter International earned a news impact score of 0.9 on InfoTrie's scale. They also gave media headlines about the medical instruments supplier a news buzz of 2.0 out of 10, meaning that recent press coverage is very unlikely to have an effect on the stock's share price in the near future.

Who are some of Baxter International's key competitors?

What other stocks do shareholders of Baxter International own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Baxter International investors own include Johnson & Johnson (JNJ), Cisco Systems (CSCO), Intel (INTC), Pfizer (PFE), CA (CA), General Electric (GE), Verizon Communications (VZ), Home Depot (HD), Micron Technology (MU) and Gilead Sciences (GILD).

Who are Baxter International's key executives?

Baxter International's management team includes the folowing people:
  • Mr. José E. Almeida, Chairman, Pres & CEO (Age 57)
  • Mr. James K. Saccaro, Exec. VP & CFO (Age 46)
  • Mr. Sean Martin, Sr. VP & Gen. Counsel (Age 56)
  • Mr. Brik V. Eyre, Sr. VP & Pres of Americas (Age 55)
  • Mr. Giuseppe Accogli, Sr. VP & Pres of Global Bus.es (Age 48)

Who are Baxter International's major shareholders?

Baxter International's stock is owned by a number of of retail and institutional investors. Top institutional investors include BlackRock Inc. (7.29%), Third Point LLC (5.26%), FMR LLC (4.52%), Northern Trust Corp (1.62%), Norges Bank (1.57%) and Geode Capital Management LLC (1.21%). Company insiders that own Baxter International stock include Albert P L Stroucken, Brik V Eyre, Carole J Shapazian, Giuseppe Accogli, James R Gavin III, Jeanne K Mason, John D Forsyth, Peter S Hellman, Scott Pleau, Third Point Llc and Thomas T Stallkamp. View Institutional Ownership Trends for Baxter International.

Which major investors are selling Baxter International stock?

BAX stock was sold by a variety of institutional investors in the last quarter, including Third Point LLC, FMR LLC, Two Sigma Advisers LP, APG Asset Management N.V., Harris Associates L P, Canada Pension Plan Investment Board, BlackRock Inc. and Standard Life Aberdeen plc. Company insiders that have sold Baxter International company stock in the last year include Brik V Eyre, Carole J Shapazian, Giuseppe Accogli, James R Gavin III, Jeanne K Mason, John D Forsyth, Peter S Hellman, Scott Pleau, Third Point Llc and Thomas T Stallkamp. View Insider Buying and Selling for Baxter International.

Which major investors are buying Baxter International stock?

BAX stock was purchased by a variety of institutional investors in the last quarter, including Norges Bank, Oregon Public Employees Retirement Fund, State of Tennessee Treasury Department, California Public Employees Retirement System, Mackenzie Financial Corp, State of New Jersey Common Pension Fund D, Eaton Vance Management and Mawer Investment Management Ltd.. View Insider Buying and Selling for Baxter International.

How do I buy shares of Baxter International?

Shares of BAX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Baxter International's stock price today?

One share of BAX stock can currently be purchased for approximately $77.24.

How big of a company is Baxter International?

Baxter International has a market capitalization of $39.59 billion and generates $11.13 billion in revenue each year. The medical instruments supplier earns $1.62 billion in net income (profit) each year or $3.05 on an earnings per share basis. Baxter International employs 50,000 workers across the globe.

What is Baxter International's official website?

The official website for Baxter International is http://www.baxter.com.

How can I contact Baxter International?

Baxter International's mailing address is One Baxter Parkway DF2-1W, DEERFIELD IL, 60015. The medical instruments supplier can be reached via phone at 224-948-2000 or via email at [email protected]


MarketBeat Community Rating for Baxter International (NYSE BAX)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  576 (Vote Outperform)
Underperform Votes:  511 (Vote Underperform)
Total Votes:  1,087
MarketBeat's community ratings are surveys of what our community members think about Baxter International and other stocks. Vote "Outperform" if you believe BAX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BAX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 3/23/2019 by MarketBeat.com Staff

Featured Article: What does EPS mean?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel